Expression of prolactin receptor and prolactin in normal and malignant thyroid: A tissue microarray study

Endocrine Pathology

Volumn 17, Issue 4, 2006, Pages 377-386

  Costa, Patrícia ^a   Catarino, Ana Luísa ^a   Silva, Fernanda ^a   Sobrinho, Luís G ^a   Bugalho, Maria João ^a,b  

^a Instituto Portugues de Oncologia de Lisboa Francisco Gentil EPE   (Portugal)

^b INSTITUTO PORTUGUÊS DE ONCOLOGIA DE LISBOA FRANCISCO GENTIL   (Portugal)

Author keywords

Medullary thyroid carcinoma; Prolactin; Prolactin receptor; Tissue microarray; TMA

Indexed keywords

PROLACTIN; PROLACTIN RECEPTOR;

ARTICLE; CANCER PATIENT; CONTROLLED STUDY; DATA ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; THYROID CANCER; THYROID CARCINOMA; THYROID GLAND; THYROID MEDULLARY CARCINOMA; TISSUE MICROARRAY;

CARCINOMA, MEDULLARY; HUMANS; IMMUNOHISTOCHEMISTRY; PROLACTIN; RECEPTORS, PROLACTIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THYROID GLAND; THYROID NEOPLASMS; TISSUE ARRAY ANALYSIS;

EID: 34347356501     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12022-006-0009-x     Document Type: Article

References (44)

1. Ben-Jonathan N, Mershon JL, Allen DL, Steinmetz RW. Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects. Endocr Rev 17:639-669, 1996.
2. Bole-Feysot C, Goffin V, Edery M, Binart N, Kelly PA. Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr Rev 19:225-268, 1998.
3. Boutin JM, Jolicoeur C, Okamura H, et al. Cloning and expression of the rat prolactin receptor, a member of the growth hormone/prolactin receptor gene family. Cell 53:69-77, 1988.
4. Bazan JF. A novel family of growth factor receptors: a common binding domain in the growth hormone, prolactin, erythropoietin and IL-6 receptors, and the p75 IL-2 receptor beta-chain. Biochem Biophys Res Commun 164:788-795, 1989.
5. Kelly PA, Djiane J, Postel-Vinay MC, Edery M. The prolactin/growth hormone receptor family. Endocr Rev 12:235-251, 1991.
6. DeVito WJ, Avakian C, Stone S, Okulicz WC. Prolactin-stimulated mitogenesis of cultured astrocytes is mediated by a protein kinase C-dependent mechanism. J Neurochem 60:832-842, 1993.
7. Leff MA, Buckley DJ, Krumenacker JS, Reed JC, Miyashita T, Buckley AR. Rapid modulation of the apoptosis regulatory genes, bcl-2 and bax by prolactin in rat Nb2 lymphoma cells. Endocrinology 137:5456-5462, 1996.
8. Flint DJ, Knight CH. Interactions of prolactin and growth hormone (GH) in the regulation of mammary gland function and epithelial cell survival. J Mammary Gland Biol Neoplasia 2:41-48, 1997.
9. Perks CM, Keith AJ, Goodhew KL, Savage PB, Winters ZE, Holly JM. Prolactin acts as a potent survival factor for human breast cancer cell lines. Br J Cancer 91:305-311, 2004.
10. Asai-Sato M, Nagashima Y, Miyagi E, et al. Prolactin inhibits apoptosis of ovarian carcinoma cells induced by serum starvation or cisplatin treatment. Int J Cancer 115:539-544, 2005.
11. Clevenger CV, Chang WP, Ngo W, Pasha TL, Montone KT, Tomaszewski JE. Expression of prolactin and prolactin receptor in human breast carcinoma. Evidence for an autocrine/paracrine loop. Am J Pathol 146:695-705, 1995.
12. Ginsburg E, Vonderhaar BK. Prolactin synthesis and secretion by human breast cancer cells. Cancer Res 55:2591-2595, 1995.
13. Tworoger SS, Eliassen AH, Rosner B, Sluss P, Hankinson SE. Plasma prolactin concentrations and risk of postmenopausal breast cancer. Cancer Res 64:6814-6819, 2004.
14. Harvey PW. Human relevance of rodent prolactin-induced non-genotoxic mammary carcinogenesis: prolactin involvement in human breast cancer and significance for toxicology risk assessments. J Appl Toxicol 25:179-183, 2005.
15. Wennbo H, Gebre-Medhin M, Gritli-Linde A, Ohlsson C, Isaksson OG, Tornell J. Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumors in transgenic mice. J Clin Invest 100:2744-2751, 1997.
16. Wennbo H, Tornell J. The role of prolactin and growth hormone in breast cancer. Oncogene 19:1072-1076, 2000.
17. Rose-Hellekant TA, Arendt LM, Schroeder MD, Gilchrist K, Sandgren EP, Schuler LA. Prolactin induces ERalpha-positive and ERalpha-negative mammary cancer in transgenic mice. Oncogene 22:4664-4674, 2003.
18. Bhatavdekar J, Patel D, Ghosh N, et al. Interrelationship of prolactin and its receptor in carcinoma of colon and rectum: a preliminary report. J Surg Oncol 55:246-249, 1994.
19. Bhatavdekar JM, Patel DD, Shah NG, et al. Prognostic value of insulin-like growth factor-1 receptors in patients with colon/rectal cancer: correlation with plasma prolactin. Eur J Surg Oncol 21:23-26, 1995.
20. Walker AM, Montgomery DW, Saraiya S, et al. Prolactin-immunoglobulin G complexes from human serum act as costimulatory ligands causing proliferation of malignant B lymphocytes. Proc Natl Acad Sci USA 92:3278-3282, 1995.
21. Gout PW, Beer CT, Noble RL. Prolactin-stimulated growth of cell cultures established from malignant Nb rat lymphomas. Cancer Res 40:2433-2436, 1980.
22. Nishiguchi Y, Hibasami H, Komada Y, Sakurai M, Nakashima K. Human promyelocytic cell line HL60 has the specific binding sites for prolactin and its ornithine decarboxylase, DNA synthesis and cellular proliferation are induced by prolactin. Leuk Res 17:633-637, 1993.
23. Ben-Jonathan N, Liby K, McFarland M, Zinger M. Prolactin as an autocrine/paracrine growth factor in human cancer. Trends Endocrinol Metab 13:245-250, 2002.
24. Camp RL, Charette LA, Rimm DL. Validation of tissue microarray technology in breast carcinoma. Lab Invest 80:1943-1949, 2000.
25. Torhorst J, Bucher C, Kononen J, et al. Tissue microarrays for rapid linking of molecular changes to clinical endpoints. Am J Pathol 159:2249-2256, 2001.
26. Banerjee R, Ginsburg E, Vonderhaar BK. Characterization of a monoclonal antibody against human prolactin receptors. Int J Cancer 55:712-721, 1993.
27. McCarty KS Jr, Miller LS, Cox EB, Konrath J, McCarty KS Sr. Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch Pathol Lab Med 109:716-721, 1985.
28. Rimm DL, Camp RL, Charette LA, Olsen DA, Provost E. Amplification of tissue by construction of tissue microarrays. Exp Mol Pathol 70:255-264, 2001.
29. Callagy G, Cattaneo E, Daigo Y, et al. Molecular classification of breast carcinomas using tissue microarrays. Diagn Mol Pathol 12:27-34, 2003.
30. Ginestier C, Charafe-Jauffret E, Bertucci F, et al. Distinct and complementary information provided by use of tissue and DNA microarrays in the study of breast tumor markers. Am J Pathol 161:1223-1233, 2002.
31. Peirce SK, Chen WY, Chen WY. Quantification of prolactin receptor mRNA in multiple human tissues and cancer cell lines by real time RT-PCR. J Endocrinol 171:R1-4, 2001.
32. Goffin V, Bernichtein S, Touraine P, Kelly PA. Development and potential clinical uses of human prolactin receptor antagonists. Endocr Rev 26:400-422, 2005.
33. Xu X, Kreye E, Kuo CB, Walker AM. A molecular mimic of phosphorylated prolactin markedly reduced tumor incidence and size when DU145 human prostate cancer cells were grown in nude mice. Cancer Res 61:6098-6104, 2001.
34. Otte JM, Otte C, Beckedorf S, et al. Expression of functional prolactin and its receptor in human colorectal cancer. Int J Colorectal Dis 18:86-94, 2003.
35. Kedzia C, Lacroix L, Ameur N, et al. Medullary thyroid carcinoma arises in the absence of prolactin signaling. Cancer Res 65:8497-8503, 2005.
36. Lu CC, Tsai SC, Huang WJ, Tsai CL, Wang PS. Effects of hyperprolactinemia on calcitonin secretion in male rats. Metabolism 48:221-226, 1999.
37. Samaan NA, Anderson GD, Adam-Mayne ME. Immunoreactive calcitonin in the mother, neonate, child and adult. Am J Obstet Gynecol 121:622-625, 1975.
38. Stevenson JC, Hillyard CJ, MacIntyre I. A physiological role for calcitonin: protection of the maternal skeleton. Lancet ii:769-770, 1979.
39. Whitehead M, Lane G, Young O, et al. Interrelations of calcium-regulating hormones during normal pregnancy. Br Med J 283:10-12, 1981.
40. Dahlman T, Sjoberg HE, Bucht E. Calcium homeostasis in normal pregnancy and puerperium. Acta Obstet Gynecol Scand 73:393-398, 1994.
41. Pitkin RM, Reynolds WA, Williams GA, Hargis GK. Calcium metabolism in normal pregnancy: a longitudinal study. Am J Obstet Gynecol 133:781-790, 1979.
42. Saggese G, Bertelloni S, Baroncelli GI, Pelletti A, Benedetti U. Evaluation of a peptide family encoded by the calcitonin gene in selected healthy pregnant women. Horm Res 34:240-244, 1990.
43. Bugalho MJ, Lacerda AJF, Santos MA, Sobrinho LG, Cabaço JM. Serum calcitonin in pregnant women determined by a two-site immunoradiometric assay using monoclonal anti-peptide antibodies. Arq Med 12:4-5, 1998.
44. Lee RC, Walters JA, Reyland ME, Anderson SM. Constitutive activation of the prolactin receptor results in the induction of growth factor-independent proliferation and constitutive activation of signaling molecules. J Biol Chem 274:10024-10034, 1999.